4 ASX shares tipped by brokers to return 18% to 96%

ASX shares closed on Tuesday afternoon off the back of a rally in ASX technology shares and a lower oil price.

Here are four ASX shares that brokers expect to outperform broader indexes over the next 12 months.

ResMed Inc (ASX: RMD)

After dipping to a multi-year low in early June, ResMed shares have rebounded by around 24% and are trading at $31.95 per share at the time of writing. They’re still around 12% lower year to date, however.

The ASX healthcare shares started climbing higher in August, and they’ve been pretty stable over the past couple of weeks. 

It looks like previous macroeconomic pressures and regulatory uncertainty have eased slightly, and investors are more optimistic about shares in the sector.

The company’s latest fourth-quarter earnings update shows the business has continued to grow at a healthy pace, and its margins have continued expanding. The company has also generated strong free cash flow. 

TradingView data shows the majority (18 out of 31) of brokers have a buy/strong buy rating on ResMed shares. The average $37.57 target price implies the shares could increase up to 18% over the next 12 months, at the time of writing.

SiteMinder Ltd (ASX: SDR)

SiteMinder shares were hit by a disappointing FY26 results announcement in mid-August. The company posted a 22% increase in revenue and a 96.5% increase in EBITDA. Its net loss also improved to $11.3 million, down from a net loss of $24.5 million in FY25. 

The company also said it expects its adjusted EBITDA margin to keep expanding in FY27 and reach the mid-20% range by FY30.

Investors weren’t thrilled and the shares crashed around 22% by the end of the month. They’ve then continued falling ever since. The ASX shares are now down around 56% for the year to date, to $2.70 each.

But it looks like the sell-off was way overdone, and at the current share price, they’re trading well below fair value.

The experts agree. TradingView data shows that the majority (13 out of 16) have a buy/strong buy rating on the ASX shares. They all agree on some element of upside ahead. The average $5.28 target price implies an upside of around 96%, at the time of writing.

Liontown Ltd (ASX: LTR)

Liontown shares enjoyed a good rally through the first quarter of 2026, but then they started tumbling around the middle of the year. At the time of writing, the shares are trading at 83 cents each, which is around 49% lower than the start of the year.

Liontown is practically a pure-play lithium miner, and its assets are overwhelmingly lithium-focused. This means it is sensitive to and heavily dependent on lithium price trajectories. This year’s crash and share price decline are almost entirely due to lithium price movements, which have followed a similar pattern.

But over the long term, the ASX shares are well placed to benefit from strong lithium pricing and expanding global EV demand. The miner’s development pipeline and exposure to future supply chains are also attractive.

TradingView data shows the majority (7 out of 14) hold a buy/strong buy rating on the shares. Another four rate the ASX shares as a hold, and three have a sell rating.

The average $1.28 target price implies an upside of around 53%, at the time of writing.

NextDC Ltd (ASX: NXT)

The data centre operator’s shares have tumbled lower over the past month, to $10.44 a piece at the time of writing. That’s 15% lower for the year to date.

It looks like the company’s latest FY26 results disappointed investors, prompting many to sell their shares. Since the announcement in late August, the ASX shares are down around 25%.

But as the company has physical centres, cooling, power, security services, and project support, and as data usage explodes, demand for secure, high-quality infrastructure is likely to boom too. 

The company is also investing heavily in business expansion, including plans to develop new facilities and expand existing sites.

Analysts are bullish that we’ll see some strong share price growth going forward.

TradingView data shows the majority (14 out of 15) have a buy/strong buy rating on the shares. The average $20.31 target price implies an upside of around 96% at the time of writing.

The post 4 ASX shares tipped by brokers to return 18% to 96% appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Buy, hold, sell: New Hope, Cleanaway Waste Management, NextDC shares
• ResMed vs Fisher & Paykel Healthcare: Which is better value?
• 5 things to watch on the ASX 200 on Monday
• Tech shares shine while ASX 200 plunges to 4-month low

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and SiteMinder. The Motley Fool Australia has positions in and has recommended ResMed and SiteMinder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.